Provided by Tiger Fintech (Singapore) Pte. Ltd.

ESSA Pharma

1.75
+0.02421.41%
Volume:97.80K
Turnover:169.43K
Market Cap:77.48M
PE:-2.72
High:1.75
Open:1.70
Low:1.70
Close:1.72
Loading ...
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
Mar 06, 2025

Major Issues Report

Form 8-K - Current report
Feb 11, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 11, 2025

Major Issues Report

Form 8-K - Current report
Dec 17, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 17, 2024

Major Issues Report

Form 8-K - Current report
Dec 16, 2024

Major Issues Report

Form 8-K - Current report
Dec 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Nov 07, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 01, 2024

Major Issues Report

Form 8-K - Current report
Sep 14, 2024

Major Issues Report

Form 8-K - Current report
Sep 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]